BDTX |
Black Diamond Therapeutics, Inc. |
Dec 13, 2024 |
1 |
$14.4K |
4 |
Dec 16, 2024 |
Director |
NEUE |
NeueHealth, Inc. |
Oct 1, 2024 |
3 |
$0 |
4 |
Oct 3, 2024 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Sep 20, 2024 |
1 |
$14.4K |
4 |
Sep 20, 2024 |
Director |
MBX |
MBX Biosciences, Inc. |
Sep 16, 2024 |
5 |
$8M |
4 |
Sep 17, 2024 |
10%+ Owner |
MBX |
MBX Biosciences, Inc. |
Sep 12, 2024 |
0 |
$0 |
3 |
Sep 12, 2024 |
10%+ Owner |
ADAP |
Adaptimmune Therapeutics PLC |
Jul 1, 2024 |
1 |
$0 |
4 |
Jul 1, 2024 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 21, 2024 |
1 |
$14.4K |
4 |
Jun 21, 2024 |
Director |
NKTX |
Nkarta, Inc. |
Jun 13, 2024 |
1 |
$0 |
4 |
Jun 14, 2024 |
Director |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 12, 2024 |
1 |
$0 |
4 |
Jun 13, 2024 |
Director, 10%+ Owner |
KRRO |
Korro Bio, Inc. |
Jun 11, 2024 |
1 |
$0 |
4 |
Jun 12, 2024 |
Director, 10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 6, 2024 |
1 |
$0 |
4 |
Jun 6, 2024 |
Director |
CVRX |
CVRx, Inc. |
Jun 4, 2024 |
1 |
$0 |
4/A |
Jun 7, 2024 |
Director |
CVRX |
CVRx, Inc. |
Jun 4, 2024 |
1 |
$0 |
4 |
Jun 6, 2024 |
Director |
CRSP |
CRISPR Therapeutics AG |
May 30, 2024 |
1 |
$0 |
4 |
May 31, 2024 |
Director |
ACLX |
Arcellx, Inc. |
May 28, 2024 |
1 |
$0 |
4 |
Jun 6, 2024 |
Director |
KRRO |
Korro Bio, Inc. |
Apr 22, 2024 |
1 |
$1M |
4 |
Apr 24, 2024 |
Director, 10%+ Owner |
NEUE |
NeueHealth, Inc. |
Apr 8, 2024 |
3 |
$0 |
4 |
Apr 10, 2024 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Mar 15, 2024 |
1 |
$14.4K |
4 |
Apr 3, 2024 |
Director |
ADAP |
Adaptimmune Therapeutics PLC |
Jan 15, 2024 |
1 |
$0 |
4 |
Jan 17, 2024 |
Director |
BHG |
Bright Health Group Inc. |
Dec 19, 2023 |
1 |
$0 |
4 |
Dec 21, 2023 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Dec 15, 2023 |
1 |
$12.2K |
4 |
Dec 15, 2023 |
Director |
CVRX |
CVRx, Inc. |
Dec 14, 2023 |
2 |
$74.90 |
4 |
Dec 18, 2023 |
Director |
FREQ |
Korro Bio, Inc. |
Nov 3, 2023 |
2 |
$0 |
4 |
Nov 7, 2023 |
Director, 10%+ Owner |
FREQ |
Korro Bio, Inc. |
Nov 3, 2023 |
0 |
$0 |
3 |
Nov 7, 2023 |
Director |
BHG |
Bright Health Group Inc. |
Oct 31, 2023 |
1 |
$0 |
4 |
Nov 2, 2023 |
10%+ Owner |
BHG |
Bright Health Group Inc. |
Sep 15, 2023 |
1 |
$0 |
4 |
Sep 19, 2023 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Sep 15, 2023 |
1 |
$11.9K |
4 |
Sep 18, 2023 |
Director |
BHG |
Bright Health Group Inc. |
Aug 11, 2023 |
1 |
$0 |
4 |
Aug 15, 2023 |
10%+ Owner |
SVRA |
Savara Inc |
Jul 17, 2023 |
1 |
$1M |
4 |
Jul 19, 2023 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Jul 5, 2023 |
1 |
$5M |
4 |
Jul 6, 2023 |
Director |
ADAP |
Adaptimmune Therapeutics PLC |
Jul 3, 2023 |
1 |
$0 |
4 |
Jul 3, 2023 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 16, 2023 |
1 |
$11.9K |
4 |
Jun 16, 2023 |
Director |
ACLX |
Arcellx, Inc. |
Jun 14, 2023 |
1 |
$0 |
4 |
Jun 16, 2023 |
Director |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 14, 2023 |
1 |
$0 |
4 |
Jun 15, 2023 |
Director, 10%+ Owner |
MIRM |
Mirum Pharmaceuticals, Inc. |
Jun 13, 2023 |
4 |
$0 |
4 |
Jun 15, 2023 |
10%+ Owner |
CRSP |
CRISPR Therapeutics AG |
Jun 8, 2023 |
1 |
$0 |
4 |
Jun 9, 2023 |
Director |
NKTX |
Nkarta, Inc. |
Jun 7, 2023 |
1 |
$0 |
4 |
Jun 9, 2023 |
Director |
CVRX |
CVRx, Inc. |
Jun 5, 2023 |
1 |
$0 |
4 |
Jun 7, 2023 |
Director |
ACLX |
Arcellx, Inc. |
Jun 1, 2023 |
2 |
$0 |
4 |
Jun 5, 2023 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
May 16, 2023 |
1 |
$0 |
4 |
May 17, 2023 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Mar 16, 2023 |
1 |
$11.9K |
4 |
Mar 20, 2023 |
Director |
OYST |
Oyster Point Pharma, Inc. |
Jan 3, 2023 |
4 |
$0 |
4 |
Jan 4, 2023 |
Director |
ACLX |
Arcellx, Inc. |
Dec 20, 2022 |
2 |
$0 |
4 |
Dec 22, 2022 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Dec 16, 2022 |
1 |
$11.9K |
4 |
Dec 19, 2022 |
Director |
AKUS |
Akouos, Inc. |
Nov 30, 2022 |
1 |
$0 |
4 |
Dec 2, 2022 |
10%+ Owner |
BHG |
Bright Health Group Inc. |
Oct 17, 2022 |
2 |
$138M |
4 |
Oct 19, 2022 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Sep 16, 2022 |
1 |
$11.9K |
4 |
Sep 19, 2022 |
Director |
ADAP |
Adaptimmune Therapeutics PLC |
Jul 1, 2022 |
1 |
$0 |
4 |
Jul 1, 2022 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 17, 2022 |
1 |
$11.9K |
4 |
Jun 17, 2022 |
Director |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 16, 2022 |
Director, 10%+ Owner |
UTRS |
MINERVA SURGICAL INC |
Jun 10, 2022 |
1 |
$120K |
4 |
Jun 14, 2022 |
Director |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 10, 2022 |
1 |
$0 |
4 |
Jun 13, 2022 |
Director |
CRSP |
CRISPR Therapeutics AG |
Jun 9, 2022 |
1 |
$0 |
4 |
Jun 10, 2022 |
Director |
NKTX |
Nkarta, Inc. |
Jun 8, 2022 |
1 |
$0 |
4 |
Jun 10, 2022 |
Director |
CVRX |
CVRx, Inc. |
Jun 7, 2022 |
1 |
$0 |
4 |
Jun 9, 2022 |
Director |
OYST |
Oyster Point Pharma, Inc. |
Jun 6, 2022 |
2 |
$0 |
4 |
Jun 8, 2022 |
Director |
GNCA |
GENOCEA BIOSCIENCES, INC. |
May 24, 2022 |
2 |
-$751K |
4 |
May 26, 2022 |
Director, 10%+ Owner |
TRVI |
Trevi Therapeutics, Inc. |
Apr 11, 2022 |
3 |
$12.5M |
4 |
Apr 13, 2022 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Mar 18, 2022 |
1 |
$13.1K |
4 |
Mar 18, 2022 |
Director |
ACLX |
Arcellx, Inc. |
Feb 3, 2022 |
0 |
$0 |
3 |
Feb 3, 2022 |
Director |
BHG |
Bright Health Group Inc. |
Jan 3, 2022 |
2 |
$200M |
4 |
Jan 5, 2022 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Dec 17, 2021 |
1 |
$13.1K |
4 |
Dec 17, 2021 |
Director |
MTCR |
Metacrine, Inc. |
Dec 10, 2021 |
3 |
-$494K |
4 |
Dec 27, 2021 |
10%+ Owner |
UTRS |
MINERVA SURGICAL INC |
Oct 26, 2021 |
20 |
-$37.4K |
4 |
Oct 28, 2021 |
Director |
UTRS |
MINERVA SURGICAL INC |
Oct 21, 2021 |
0 |
$0 |
3 |
Oct 21, 2021 |
Director |
TRVI |
Trevi Therapeutics, Inc. |
Oct 18, 2021 |
3 |
$0 |
4 |
Oct 19, 2021 |
10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Sep 17, 2021 |
1 |
$13.1K |
4 |
Sep 23, 2021 |
Director |
ADAP |
Adaptimmune Therapeutics PLC |
Jul 1, 2021 |
1 |
$0 |
4 |
Jul 2, 2021 |
Director |
GNCA |
GENOCEA BIOSCIENCES, INC. |
Jul 1, 2021 |
1 |
$0 |
4 |
Jul 2, 2021 |
Director, 10%+ Owner |
CVRX |
CVRx, Inc. |
Jun 29, 2021 |
1 |
$0 |
4 |
Jul 1, 2021 |
Director |
CVRX |
CVRx, Inc. |
Jun 29, 2021 |
0 |
$0 |
3 |
Jun 29, 2021 |
Director |
BHG |
Bright Health Group Inc. |
Jun 28, 2021 |
12 |
$35M |
4 |
Jun 30, 2021 |
10%+ Owner |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 28, 2021 |
7 |
$20M |
4 |
Jun 30, 2021 |
Director, 10%+ Owner |
BHG |
Bright Health Group Inc. |
Jun 24, 2021 |
0 |
$0 |
3 |
Jun 24, 2021 |
10%+ Owner |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 23, 2021 |
1 |
$0 |
4 |
Jun 25, 2021 |
Director, 10%+ Owner |
GLUE |
Monte Rosa Therapeutics, Inc. |
Jun 23, 2021 |
0 |
$0 |
3 |
Jun 23, 2021 |
Director, 10%+ Owner |
BDTX |
Black Diamond Therapeutics, Inc. |
Jun 18, 2021 |
2 |
$13.1K |
4 |
Jun 22, 2021 |
Director |
NKTX |
Nkarta, Inc. |
Jun 13, 2021 |
1 |
$0 |
4 |
Jun 15, 2021 |
Director |
CRSP |
CRISPR Therapeutics AG |
Jun 10, 2021 |
1 |
$0 |
4 |
Jun 14, 2021 |
Director |
OYST |
Oyster Point Pharma, Inc. |
Jun 7, 2021 |
2 |
$0 |
4 |
Jun 9, 2021 |
Director |